Bioorganic and Medicinal Chemistry Letters p. 2635 - 2640 (1998)
Update date:2022-08-03
Topics:
Montana, John G.
Buckley, George M.
Cooper, Nicola
Dyke, Hazel J.
Gowers, Lewis
Gregory, Joanna P.
Hellewell, Paul G.
Kendall, Hannah J.
Lowe, Christopher
Maxey, Robert
Miotla, Jadwiga
Naylor, Robert J.
Runcie, Karen A.
Tuladhar, Bishwa
Warneck, Julie B. H.
A series of novel selective phosphodiesterase 4 (PDE4) inhibitors has been developed which displays activity both in vitro and in vivo. These compounds possess good selectivity for the catalytic site of PDE4 over the high affinity Rolipram binding site. In vivo studies demonstrate a reduced propensity to display the emetic side effects which are commonly observed with PDE4 inhibitors.
View MoreShanghai Rich Chemicals Co., Ltd
website:http://www.richchemical.com
Contact:+86-21-20255798
Address:Pudong Shanghai,China
HANGZHOU TOYOND BIOTECH CO., LTD
Contact:+86-571-86965177
Address:No. 189, Fengqi East Road, Hangzhou, China
Contact:+86-0592 5353131
Address:No.56 Guani Road Software Park 2,Siming District
Contact:+86-0760-85282375
Address:zhongjing road,zhongshan torch hi-tech industrial development zone
JIAXING SUNS INTERNATIONAL TRADE CO LTD
Contact:18367306858
Address:No.123,Huixin Avenue,Huimin Dist
Doi:10.1021/jm301217c
(2012)Doi:10.1021/ic300872m
(2012)Doi:10.1021/jm301212u
(2012)Doi:10.1007/BF00901092
(1967)Doi:10.1039/c2ob26103k
(2012)Doi:10.1016/j.bmcl.2012.08.089
(2012)
